This site uses cookies to bring you the best experience. Find out more
Skip to main content

Discover our world-class facilities

With a development pipeline of over 600,000 sq ft due to be
delivered by the end of 2026, The Oxford Science Park is the
ideal home for occupiers to expand.

Discover the park

 

Close to 100 pioneering organisations

With more than 3000 employees


Who's Here

£2bn Raised

By Occupiers Since January 2020


Explore Careers

With a development pipeline of over 600,000 sq ft

due to be delivered by the end of 2026, The Oxford Science Park is the ideal home for occupiers to expand.


Our Developments

Six

New buildings planned


Explore the Sitemap

Rare and Major Diseases

Being researched


Who's Here

LATEST NEWS

Tres Alchemix raises $4.4M in Series A funding to accelerate AI-driven drug discovery

26 . 09 . 25

Tres Alchemix, an early-stage biotechnology company applying artificial intelligence (AI) to drug discovery, today announced it has closed a $4.4 million Series A financing. The round was led by DNX Ventures, with participation from existing...

Read More